The role of Na,K‑ATPase in lung diseases (Review)

Skou JC: The influence of some cations on an adenosine triphosphatase from peripheral nerves. Biochim Biophys Acta. 23:394–401. 1957. View Article : Google Scholar : PubMed/NCBI

Kaplan JH: Biochemistry of Na,K-ATPase. Annu Rev Biochem. 71:511–535. 2002. View Article : Google Scholar : PubMed/NCBI

Mobasheri A, Avila J, Cózar-Castellano I, Brownleader MD, Trevan M, Francis MJ, Lamb JF and Martín-Vasallo P: Na+, K+-ATPase isozyme diversity; comparative biochemistry and physiological implications of novel functional interactions. Biosci Rep. 20:51–91. 2000. View Article : Google Scholar : PubMed/NCBI

Rajasekaran SA, Gopal J, Willis D, Espineda C, Twiss JL and Rajasekaran AK: Na,K-ATPase beta1-subunit increases the translation efficiency of the alpha1-subunit in MSV-MDCK cells. Mol Biol Cell. 15:3224–3232. 2004. View Article : Google Scholar : PubMed/NCBI

Blanco G, Sánchez G and Mercer RW: Differential regulation of Na,K-ATPase isozymes by protein kinases and arachidonic acid. Arch Biochem Biophys. 359:139–150. 1998. View Article : Google Scholar : PubMed/NCBI

Benarroch EE: Na+, K+-ATPase: Functions in the nervous system and involvement in neurologic disease. Neurology. 76:287–293. 2011. View Article : Google Scholar : PubMed/NCBI

Lemas MV, Hamrick M, Takeyasu K and Fambrough DM: 26 Amino acids of an extracellular domain of the Na,K-ATPase alpha-subunit are sufficient for assembly with the Na,K-ATPase beta-subunit. J Biol Chem. 269:8255–8259. 1994. View Article : Google Scholar : PubMed/NCBI

Geering K, Meyer DI, Paccolat MP, Kraehenbühl JP and Rossier BC: Membrane insertion of alpha- and beta-subunits of Na+,K+-ATPase. J Biol Chem. 260:5154–5160. 1985. View Article : Google Scholar : PubMed/NCBI

Blanco G: Na,K-ATPase subunit heterogeneity as a mechanism for tissue-specific ion regulation. Semin Nephrol. 25:292–303. 2005. View Article : Google Scholar : PubMed/NCBI

Geering K: Functional roles of Na,K-ATPase subunits. Curr Opin Nephrol Hypertens. 17:526–532. 2008. View Article : Google Scholar : PubMed/NCBI

Geering K: FXYD proteins: new regulators of Na-K-ATPase. Am J Physiol Renal Physiol. 290:F241–F250. 2006. View Article : Google Scholar : PubMed/NCBI

Contreras RG, Torres-Carrillo A, Flores-Maldonado C, Shoshani L and Ponce A: Na⁺/K⁺-ATPase: More than an electrogenic pump. Int J Mol Sci. 25:61222024. View Article : Google Scholar : PubMed/NCBI

Laursen M, Gregersen JL, Yatime L, Nissen P and Fedosova UN: Structures and characterization of digoxin- and bufalin-bound Na+,K+-ATPase compared with the ouabain-bound complex. Proc Natl Acad Sci USA. 112:1755–1760. 2015. View Article : Google Scholar : PubMed/NCBI

Quintas LE, Pierre SV, Liu LJ, Bai Y, Liu XC and Xie ZJ: Alterations of Na+/K+-ATPase function in caveolin-1 knockout cardiac fibroblasts. J Mol Cell Cardiol. 49:525–531. 2010. View Article : Google Scholar : PubMed/NCBI

Skou JC: The identification of the sodium pump. Biosci Rep. 24:436–451. 2004. View Article : Google Scholar : PubMed/NCBI

Xie ZJ and Askari A: Na(+)/K(+)-ATPase as a signal transducer. Eur J Biochem. 269:2434–2439. 2002. View Article : Google Scholar : PubMed/NCBI

Pierre SV and Xie Z: The Na,K-ATPase receptor complex: Its organization and membership. Cell Biochem Biophys. 46:303–316. 2006. View Article : Google Scholar : PubMed/NCBI

Rajasekaran SA and Rajasekaran AK: Na,K-ATPase and epithelial tight junctions. Front Biosci (Landmark Ed). 14:2130–2148. 2009. View Article : Google Scholar : PubMed/NCBI

Barwe SP, Anikmar G, Moon SY, Zeng Y, Whitelegge JP, Rajasekaran SA and Rajasekaran AK: Novel role for Na,K-ATPase in phosphatidylinositol 3-kinase signaling and suppression of cell motility. Mol Biol Cell. 16:1082–1094. 2005. View Article : Google Scholar : PubMed/NCBI

Kimura T, Han W, Pagel P, Nairn AC and Caplan MJ: Protein phosphatase 2A interacts with the Na,K-ATPase and modulates its trafficking by inhibition of its association with arrestin. PLoS One. 6:e292692011. View Article : Google Scholar : PubMed/NCBI

Ren Y, Anderson AT, Meyer G, Lauber KM, Gallucci JC and Douglas Kinghorn A: Digoxin and its Na⁺/K⁺-ATPase-targeted actions on cardiovascular diseases and cancer. Bioorg Med Chem. 114:1179392024. View Article : Google Scholar : PubMed/NCBI

Maxwell KD, Chuang J, Chaudhry M, Nie Y, Bai F, Sodhi K, Liu J and Shapiro JI: The potential role of Na-K-ATPase and its signaling in the development of anemia in chronic kidney disease. Am J Physiol Renal Physiol. 320:F234–F242. 2021. View Article : Google Scholar : PubMed/NCBI

Bartlett DE, Miller RB, Thiesfeldt S, Lakhani HV, Shapiro JI and Sodhi K: The role of Na/K-ATPase signaling in oxidative stress related to aging: Implications in obesity and cardiovascular disease. Int J Mol Sci. 19:21392018. View Article : Google Scholar : PubMed/NCBI

Thai AA, Solomon BJ, Sequist LV, Gainor JF and Heist RE: Lung cancer. Lancet. 398:535–554. 2021. View Article : Google Scholar : PubMed/NCBI

Hirsch FR, Scagliotti GV, Mulshine JL, Kwon R, Curran WJ Jr, Wu YL and Paz-Ares L: Lung cancer: Current therapies and new targeted treatments. Lancet. 389:299–311. 2017. View Article : Google Scholar : PubMed/NCBI

Luo G, Zhang Y, Rumgay H, Morgan E, Langselius O, Vignat J, Colombet M and Bray F: Estimated worldwide variation and trends in incidence of lung cancer by histological subtype in 2022 and over time: A population-based study. Lancet Respir Med. 13:348–363. 2025. View Article : Google Scholar : PubMed/NCBI

Hirsch FR, Suda K, Wiens J and Bunn PA Jr: New and emerging targeted treatments in advanced non-small-cell lung cancer. Lancet. 388:1012–1024. 2016. View Article : Google Scholar : PubMed/NCBI

Stenkvist B, Bengtssion E, Dahlqvist B, Eriksson O, Jarkrans T and Nordin B: Cardiac glycosides and breast cancer, revisited. N Engl J Med. 306:4841982. View Article : Google Scholar : PubMed/NCBI

Siegel RL, Giaquinto AN and Jemal A: Cancer statistics, 2024. CA Cancer J Clin. 74:12–49. 2024.PubMed/NCBI

Felippe Gonçalves-de-Albuquerque C, Ribeiro Silva A, Ignácio da Silva C, Caire Castro-Faria-Neto H and Burth P: Na/K pump and beyond: Na/K-ATPase as a modulator of apoptosis and autophagy. Molecules. 22:5782017. View Article : Google Scholar : PubMed/NCBI

Bejček J, Spiwok V, Kmoníčková E and Rimpelová S: Na⁺/K⁺-ATPase revisited: On its mechanism of action, role in cancer, and activity modulation. Molecules. 26:19052021. View Article : Google Scholar : PubMed/NCBI

Diederich M, Muller F and Cerella C: Cardiac glycosides: From molecular targets to immunogenic cell death. Biochem Pharmacol. 125:1–11. 2017. View Article : Google Scholar : PubMed/NCBI

Huynh TP, Mah V, Sampson VB, Chia D, Fishbein MC, Horvath S, Alavi M, Wu DC, Harper J, Sarafian T, et al: Na,K-ATPase is a target of cigarette smoke and reduced expression predicts poor patient outcome of smokers with lung cancer. Am J Physiol Lung Cell Mol Physiol. 302:L1150–L1158. 2012. View Article : Google Scholar : PubMed/NCBI

Schneider C, Spaink H, Alexe G, Dharia NV, Meyer A, Merickel LA, Khalid D, Scheich S, Häupl B, Staudt LM, et al: Targeting the sodium-potassium pump as a therapeutic strategy in acute myeloid leukemia. Cancer Res. 84:3354–3370. 2024. View Article : Google Scholar : PubMed/NCBI

Espineda C, Seligson DB, Ball WJ Jr, Rao JY, Palotie A, Horvath S, Huang Y, Shi T and Rajasekaran AK: Analysis of the Na,K-ATPase alpha- and beta-subunit expression profiles of bladder cancer using tissue microarrays. Cancer. 97:1859–1868. 2003. View Article : Google Scholar : PubMed/NCBI

Rajasekaran SA, Ball WJ Jr, Bander NH, Liu H, Pardee JD and Rajasekaran AK: Reduced expression of beta-subunit of Na,K-ATPase in human clear-cell renal cell carcinoma. J Urol. 162:574–580. 1999. View Article : Google Scholar : PubMed/NCBI

Rajasekaran SA, Huynh TP, Wolle DG, Espineda CE, Inge LJ, Skay A, Lassman C, Nicholas SB, Harper JF, Reeves AE, et al: Na,K-ATPase subunits as markers for epithelial-mesenchymal transition in cancer and fibrosis. Mol Cancer Ther. 9:1515–1524. 2010. View Article : Google Scholar : PubMed/NCBI

Rajasekaran SA, Palmer LG, Moon SY, Soler AP, Apodaca GL, Harper JF, Zheng Y and Rajasekaran AK: Na,K-ATPase activity is required for formation of tight junctions, desmosomes, and induction of polarity in epithelial cells. Mol Biol Cell. 12:3717–3732. 2001. View Article : Google Scholar : PubMed/NCBI

Barwe SP, Kim S, Rajasekaran SA, Bowie JU and Rajasekaran KA: Janus model of the Na,K-ATPase beta-subunit transmembrane domain: Distinct faces mediate alpha/beta assembly and beta-beta homo-oligomerization. J Mol Biol. 365:706–714. 2007. View Article : Google Scholar : PubMed/NCBI

Inge LJ, Rajasekaran SA, Yoshimoto K, Mischel PS, McBride W, Landaw E and Rajasekaran KA: Evidence for a potential tumor suppressor role for the Na,K-ATPase beta1-subunit. Histol Histopathol. 23:459–467. 2008.PubMed/NCBI

Shoshani L, Contreras RG, Roldán ML, Moreno J, Lázaro A, Balda MS, Matter K and Cereijido M: The polarized expression of Na+,K+-ATPase in epithelia depends on the association between beta-subunits located in neighboring cells. Mol Biol Cell. 16:1071–1081. 2005. View Article : Google Scholar : PubMed/NCBI

Vagin O, Tokhtaeva E and Sachs G: The role of the beta1 subunit of the Na,K-ATPase and its glycosylation in cell-cell adhesion. J Biol Chem. 281:39573–39587. 2006. View Article : Google Scholar : PubMed/NCBI

Udoh UaS, Banerjee M, Rajan PK, Sanabria JD, Smith G, Schade M, Sanabria JA, Nakafuku Y, Sodhi K, Pierre SV, et al: Tumor-suppressor role of the α1-Na/K-ATPase signalosome in NASH related hepatocellular carcinoma. Int J Mol Sci. 23:73592022. View Article : Google Scholar : PubMed/NCBI

Mijatovic T, Roland I, Quaquebeke EV, Nilsson B, Mathieu A, Vynckt FV, Darro F, Blanco G, Facchini V and Kiss R: The alpha1 subunit of the sodium pump could represent a novel target to combat non-small cell lung cancers. J Pathol. 212:170–179. 2007. View Article : Google Scholar : PubMed/NCBI

Liu CC, Kim YJ, Teh R, Garcia A, Hamilton EJ, Cornelius F, Baxter RC and Rasmussen HH: Displacement of native FXYD protein from Na⁺/K⁺-ATPase with novel FXYD peptide derivatives: Effects on doxorubicin cytotoxicity. Front Oncol. 12:8592162022. View Article : Google Scholar : PubMed/NCBI

Liu CC, Teh R, Mozar CA, Baxter RC and Rasmussen HH: Silencing overexpression of FXYD3 protein in breast cancer cells amplifies effects of doxorubicin and γ-radiation on Na(+)/K(+)-ATPase and cell survival. Breast Cancer Res Treat. 155:203–213. 2016. View Article : Google Scholar : PubMed/NCBI

Cordeiro BM, Leite Fontes CF and Meyer-Fernandes JR: Molecular basis of Na, K-ATPase regulation of diseases: Hormone and FXYD2 interactions. Int J Mol Sci. 25:133982024. View Article : Google Scholar : PubMed/NCBI

Okudela K, Yazawa T, Ishii J, Woo T, Mitsui H, Bunai T, Sakaeda M, Shimoyamada H, Sato H, Tajiri M, et al: Down-regulation of FXYD3 expression in human lung cancers: Its mechanism and potential role in carcinogenesis. Am J Pathol. 175:2646–2656. 2009. View Article : Google Scholar : PubMed/NCBI

Liu J, Feng Y, Zeng X, He M, Gong Y and Liu Y: Extracellular vesicles-encapsulated let-7i shed from bone mesenchymal stem cells suppress lung cancer via KDM3A/DCLK1/FXYD3 axis. J Cell Mol Med. 25:1911–1926. 2021. View Article : Google Scholar : PubMed/NCBI

Crambert G, Li C, Claeys D and Geering K: FXYD3 (Mat-8), a new regulator of Na,K-ATPase. Mol Biol Cell. 16:2363–2371. 2005. View Article : Google Scholar : PubMed/NCBI

Glaviano A, Foo ASC, Lam HY, Yap KCH, Jacot W, Jones RH, Eng H, Nair MG, Makvandi P, Geoerger B, et al: PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer. 22:1382023. View Article : Google Scholar : PubMed/NCBI

LoPiccolo J, Blumenthal GM, Bernstein WB and Dennis PA: Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations. Drug Resist Updat. 11:32–50. 2008. View Article : Google Scholar : PubMed/NCBI

Ren Y, Wu S, Burdette JE, Cheng X and Kinghorn AD: Structural insights into the interactions of digoxin and Na⁺/K⁺-ATPase and other targets for the inhibition of cancer cell proliferation. Molecules. 26:36722021. View Article : Google Scholar : PubMed/NCBI

Zhu Z, Sun H, Ma G, Wang Z, Li E and Liu Y and Liu Y: Bufalin induces lung cancer cell apoptosis via the inhibition of PI3K/Akt pathway. Int J Mol Sci. 13:2025–2035. 2012. View Article : Google Scholar : PubMed/NCBI

Chanvorachote P and Pongrakhananon V: Ouabain downregulates Mcl-1 and sensitizes lung cancer cells to TRAIL-induced apoptosis. Am J Physiol Cell Physiol. 304:C263–C272. 2013. View Article : Google Scholar : PubMed/NCBI

Yang K, Li Z, Chen Y, Yin F, Ji X, Zhou J, Li X, Zeng T, Fei C, Ren C, et al: Na, K-ATPase α1 cooperates with its endogenous ligand to reprogram immune microenvironment of lung carcinoma and promotes immune escape. Sci Adv. 9:eade53932023. View Article : Google Scholar : PubMed/NCBI

Song X, Xie L, Wang X, Zeng Q, Chen TC, Wang W and Song X: Temozolomide-perillyl alcohol conjugate induced reactive oxygen species accumulation contributes to its cytotoxicity against non-small cell lung cancer. Sci Rep. 6:227622016. View Article : Google Scholar : PubMed/NCBI

Lauf PK, Alqahtani T, Flues K, Meller L and Adragna NC: Interaction between Na-K-ATPase and Bcl-2 proteins BclXL and Bak. Am J Physiol Cell Physiol. 308:C51–C60. 2015. View Article : Google Scholar : PubMed/NCBI

Sun J, Chen L, Jiang P, Duan B, Wang R, Xu J, Liu W, Xu Y, Xie Z, Feng F and Qu W: Phenylethanoid glycosides of Callicarpa kwangtungensis Chun exert cardioprotective effect by weakening Na+-K+-ATPase/Src/ERK1/2 pathway and inhibiting apoptosis mediated by oxidative stress and inflammation. J Ethnopharmacol. 258:1128812020. View Article : Google Scholar : PubMed/NCBI

Wang Z, Pei S, Cui H, Zhang J and Jia Z: Zoonotic spillover and extreme weather events drive the global outbreaks of airborne viral emerging infectious diseases. J Med Virol. 96:e297372024. View Article : Google Scholar : PubMed/NCBI

Majumder J and Minko T: Recent developments on therapeutic and diagnostic approaches for COVID-19. AAPS J. 23:142021. View Article : Google Scholar : PubMed/NCBI

Ochani R, Asad A, Yasmin F, Shaikh S, Khalid H, Batra S, Sohail MR, Mahmood SF, Ochani R, Hussham Arshad M, et al: COVID-19 pandemic: From origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management. Infez Med. 29:20–36. 2021.PubMed/NCBI

Nyachoti DO, Fwelo P, Springer AE and Kelder SH: Association between gross national income per capita and COVID-19 vaccination coverage: A global ecological study. BMC Public Health. 23:24152023. View Article : Google Scholar : PubMed/NCBI

de Wit E, van Doremalen N, Falzarano D and Munster VJ: SARS and MERS: Recent insights into emerging coronaviruses. Nat Rev Microbiol. 14:523–534. 2016. View Article : Google Scholar : PubMed/NCBI

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, et al: Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 382:1708–1720. 2020. View Article : Google Scholar : PubMed/NCBI

Vitalii K and István V: Molecular mechanisms of Na,K-ATPase dysregulation driving alveolar epithelial barrier failure in severe COVID-19. Am J Physiol Lung Cell Mol Physiol. 320:L1186–L1193. 2021. View Article : Google Scholar : PubMed/NCBI

Souza E, Souza KFC, Moraes BPT, Paixão ICNP, Burth P, Silva AR and Gonçalves-de-Albuquerque CF: Na⁺/K⁺-ATPase as a target of cardiac glycosides for the treatment of SARS-CoV-2 infection. Front Pharmacol. 12:6247042021. View Article : Google Scholar : PubMed/NCBI

Blanco-Melo D, Nilsson-Payant BE, Liu WC, Uhl S, Hoagland D, Møller R, Jordan TX, Oishi K, Panis M, Sachs D, et al: Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. 181:1036–1045.e9. 2020. View Article : Google Scholar : PubMed/NCBI

Chen F, Zhang Y, Sucgang R, Ramani S, Corry D, Kheradmand F and Creighton CJ: Meta-analysis of host transcriptional responses to SARS-CoV-2 infection reveals their manifestation in human tumors. Sci Rep. 11:24592021. View Article : Google Scholar : PubMed/NCBI

Ambade V and Ambade S: SARS-CoV-2 infecting endothelial cells, biochemical alterations, autopsy findings and outcomes in COVID-19, suggest role of hypoxia-inducible factor-1. J Med Biochem. 41:14–20. 2022. View Article : Google Scholar : PubMed/NCBI

Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ and van Goor H: Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 203:631–637. 2004. View Article : Google Scholar : PubMed/NCBI

Xie ZJ, Novograd J, Itzkowitz Y, Sher A, Buchen YD, Sodhi K, Abraham NG and Shapiro JI: The pivotal role of adipocyte-Na K peptide in reversing systemic inflammation in obesity and COVID-19 in the development of heart failure. Antioxidants (Basel). 9:11292020. View Article : Google Scholar : PubMed/NCBI

Li F, Li J, Wang PH, Yang N, Huang J, Ou J, Xu T, Zhao X, Liu T, Huang X, et al: SARS-CoV-2 spike promotes inflammation and apoptosis through autophagy by ROS-suppressed PI3K/AKT/mTOR signaling. Biochim Biophys Acta Mol Basis Dis. 1867:1662602021. View Article : Google Scholar : PubMed/NCBI

Basile MS, Cavalli E, McCubrey J, Hernández-Bello J, Muñoz-Valle JF, Fagone P and Nicoletti F: The PI3K/Akt/mTOR pathway: A potential pharmacological target in COVID-19. Drug Discov Today. 27:848–856. 2022. View Article : Google Scholar : PubMed/NCBI

Semenza GL: Hypoxia-inducible factors in physiology and medicine. Cell. 148:399–408. 2012. View Article : Google Scholar : PubMed/NCBI

Zhang H, Qian DZ, Tan YS, Lee K, Gao P, Ren YR, Rey S, Hammers H, Chang D, Pili R, et al: Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth. Proc Natl Acad Sci USA. 105:19579–19586. 2008. View Article : Google Scholar : PubMed/NCBI

Ha DP, Shin WJ, Liu Z, Doche MiE, Lau R, Leli NM, Conn CS, Russo M, Lorenzato A, Koumenis C, et al: Targeting stress induction of GRP78 by cardiac glycoside oleandrin dually suppresses cancer and COVID-19. Cell Biosci. 14:1152024. View Article : Google Scholar : PubMed/NCBI

Newman RA, Sastry KJ, Arav-Boger R, Cai H, Matos R and Harrod R: Antiviral effects of oleandrin. J Exp Pharmacol. 12:503–515. 2020. View Article : Google Scholar : PubMed/NCBI

Van Kanegan MJ, Dunn DE, Kaltenbach LS, Shah B, He DN, McCoy DD, Yang PY, Peng JN, Shen L, Du L, et al: Dual activities of the anti-cancer drug candidate PBI-05204 provide neuroprotection in brain slice models for neurodegenerative diseases and stroke. Sci Rep. 6:256262016. View Article : Google Scholar : PubMed/NCBI

RECOVERY Collaborative Group and Horby P, ; Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, et al: Dexamethasone in hospitalized patients with Covid-19-preliminary report. N Engl J Med. 384:693–704. 2021. View Article : Google Scholar : PubMed/NCBI

Devarajan P and Benz EJ Jr: Translational regulation of Na-K-ATPase subunit mRNAs by glucocorticoids. Am J Physiol Renal Physiol. 279:F1132–F1138. 2000. View Article : Google Scholar : PubMed/NCBI

Matthay MA, Arabi Y, Arroliga AC, Bernard G, Bersten AD, Brochard LJ, Calfee CS, Combes A, Daniel BM, Ferguson ND, et al: A new global definition of acute respiratory distress syndrome. Am J Respir Crit Care Med. 209:37–47. 2024. View Article : Google Scholar : PubMed/NCBI

Matthay MA, Zemans RL, Zimmerman GA, Arabi YM, Beitler JR, Mercat A, Herridge M, Randolph AG and Calfee CS: Acute respiratory distress syndrome. Nat Rev Dis Primers. 5:182019. View Article : Google Scholar : PubMed/NCBI

Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, LeGall JR, Morris A and Spragg R: Report of the American-European consensus conference on ARDS: Definitions, mechanisms, relevant outcomes and clinical trial coordination. The consensus committee. Intensive Care Med. 20:225–232. 1994. View Article : Google Scholar : PubMed/NCBI

ARDS Definition Task Force, . Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L and Slutsky AS: Acute respiratory distress syndrome: The Berlin definition. JAMA. 307:2526–2533. 2012.PubMed/NCBI

Hu Q, Zhang S, Yang Y, Yao JQ, Tang WF, Lyon CJ, Hu TY and Wan MH: Extracellular vesicles in the pathogenesis and treatment of acute lung injury. Mil Med Res. 9:612022.PubMed/NCBI

Meyer NJ, Gattinoni L and Calfee CS: Acute respiratory distress syndrome. Lancet. 398:622–637. 2021. View Article : Google Scholar : PubMed/NCBI

Herold S, Gabrielli NM and Vadász I: Novel concepts of acute lung injury and alveolar-capillary barrier dysfunction. Am J Physiol Lung Cell Mol Physiol. 305:L665–L681. 2013. View Article : Google Scholar : PubMed/NCBI

Matthay MA, Folkesson HG and Clerici C: Lung epithelial fluid transport and the resolution of pulmonary edema. Physiol Rev. 82:569–600. 2002. View Article : Google Scholar : PubMed/NCBI

Gusarova GA, Trejo HE, Dada LA, Briva A, Welch LC, Hamanaka RB, Mutlu GM, Chandel NS, Prakriya M and Sznajder JI: Hypoxia leads to Na,K-ATPase downregulation via Ca(2+) release-activated Ca(2+) channels and AMPK activation. Mol Cell Biol. 31:3546–3556. 2011. View Article : Google Scholar : PubMed/NCBI

Berger G, Guetta J, Klorin G, Badarneh R, Braun E, Brod V, Saleh NA, Katz A, Bitterman H and Azzam ZS: Sepsis impairs alveolar epithelial function by downregulating Na-K-ATPase pump. Am J Physiol Lung Cell Mol Physiol. 301:L23–L30. 2011. View Article : Google Scholar : PubMed/NCBI

Peteranderl C, Morales-Nebreda L, Selvakumar B, Lecuona E, Vadász I, Morty RE, Schmoldt C, Bespalowa J, Wolff T, Pleschka S, et al: Macrophage-epithelial paracrine crosstalk inhibits lung edema clearance during influenza infection. J Clin Invest. 126:1566–1580. 2016. View Article : Google Scholar : PubMed/NCBI

Gonçalves-de-Albuquerque CF, Silva AR, Burth P, Castro-Faria MV and Castro-Faria-Neto HC: Acute Respiratory Distress Syndrome: Role of oleic acid-triggered lung injury and inflammation. Mediators Inflamm. 2015:2604652015. View Article : Google Scholar : PubMed/NCBI

Gonçalves-de-Albuquerque CF, Burth P, Silva AR, de Moraes IM, de Jesus Oliveira FM, Santelli RE, Freire AS, Bozza PT, Younes-Ibrahim M and de Castro-Faria MV: Oleic acid inhibits lung Na/K-ATPase in mice and induces injury with lipid body formation in leukocytes and eicosanoid production. J Inflamm (Lond). 10:342013. View Article : Google Scholar : PubMed/NCBI

Silva AR, de Souza E Souza KFC, Souza TB, Younes-Ibrahim M, Burth P, de Castro Faria Neto HC and Gonçalves-de-Albuquerque CF: The Na/K-ATPase role as a signal transducer in lung inflammation. Front Immunol. 14:12875122024. View Article : Google Scholar : PubMed/NCBI

Lei J and Ingbar DH: Src kinase integrates PI3K/Akt and MAPK/ERK1/2 pathways in T3-induced Na-K-ATPase activity in adult rat alveolar cells. Am J Physiol Lung Cell Mol Physiol. 301:L765–L771. 2011. View Article : Google Scholar : PubMed/NCBI

Upadhyay D, Lecuona E, Comellas A, Kamp DW and Sznajder JI: Fibroblast growth factor-10 upregulates Na,K-ATPase via the MAPK pathway. FEBS Lett. 545:173–176. 2003. View Article : Google Scholar : PubMed/NCBI

Wang Q, Yan SF, Hao Y and Jin SW: Specialized pro-resolving mediators regulate alveolar fluid clearance during acute respiratory distress syndrome. Chin Med J (Engl). 131:982–989. 2018. View Article : Google Scholar : PubMed/NCBI

Zhang JL, Zhuo XJ, Lin J, Luo LC, Ying WY, Xie X, Zhang HW, Yang JX, Li D, Smith FG and Jin SW: Maresin1 stimulates alveolar fluid clearance through the alveolar epithelial sodium channel Na,K-ATPase via the ALX/PI3K/Nedd4-2 pathway. Lab Invest. 97:543–554. 2017. View Article : Google Scholar : PubMed/NCBI

Yang Q, Xu HR, Xiang SY, Zhang C, Ye Y, Shen CX, Mei HX, Zhang PH, Ma HY, Zheng SX, et al: Resolvin conjugates in tissue regeneration 1 promote alveolar fluid clearance by activating alveolar epithelial sodium channels and Na, K-ATPase in lipopolysaccharide-induced acute lung injury. J Pharmacol Exp Ther. 379:156–165. 2021. View Article : Google Scholar : PubMed/NCBI

Wang C, Meng Y, Wang Y, Jiang Z, Xu M, Bo L and Deng X: Ouabain protects mice against lipopolysaccharide-induced acute lung injury. Med Sci Monit. 24:4455–4464. 2018. View Article : Google Scholar : PubMed/NCBI

Wang Q, Lian QQ, Li R, Ying BY, He Q, Chen F, Zheng X, Yang Y, Wu DR, Zheng SX, et al: Lipoxin A(4) activates alveolar epithelial sodium channel, Na,K-ATPase, and increases alveolar fluid clearance. Am J Respir Cell Mol Biol. 48:610–618. 2013. View Article : Google Scholar : PubMed/NCBI

Emr BM, Roy S, Kollisch-Singule M, Gatto LA, Barravecchia M, Lin X, Young JL, Wang G, Liu J, Satalin J, et al: Electroporation-mediated gene delivery of Na+,K+-ATPase, and ENaC subunits to the lung attenuates acute respiratory distress syndrome in a two-hit porcine model. Shock. 43:16–23. 2015. View Article : Google Scholar : PubMed/NCBI

Stern M, Ulrich K, Robinson C, Copeland J, Griesenbach U, Masse C, Cheng S, Munkonge F, Geddes D, Berthiaume Y and Alton E: Pretreatment with cationic lipid-mediated transfer of the Na+K+-ATPase pump in a mouse model in vivo augments resolution of high permeability pulmonary edema. Gene Ther. 7:960–966. 2000. View Article : Google Scholar : PubMed/NCBI

Zhang J, Chang J, Beg MA, Huang W, Zhao Y, Dai W, Wu X, Cui W, Pillai SS, Lakhani HV, et al: Na/K-ATPase suppresses LPS-induced pro-inflammatory signaling through Lyn. iScience. 25:1049632022. View Article : Google Scholar : PubMed/NCBI

Flodby P, Kim YH, Beard LL, Gao D, Ji Y, Kage H, Liebler JM, Minoo P, Kim KJ, Borok Z and Crandall ED: Knockout mice reveal a major role for alveolar epithelial type I cells in alveolar fluid clearance. Am J Respir Cell Mol Biol. 55:395–406. 2016. View Article : Google Scholar : PubMed/NCBI

Li G, Flodby P, Luo J, Kage H, Sipos A, Gao D, Ji Y, Beard LL, Marconett CN, DeMaio L, et al: Knockout mice reveal key roles for claudin 18 in alveolar barrier properties and fluid homeostasis. Am J Respir Cell Mol Biol. 51:210–222. 2014. View Article : Google Scholar : PubMed/NCBI

Lin X, Barravecchia M, Kothari P, Young JL and Dean DA: β1-Na(+),K(+)-ATPase gene therapy upregulates tight junctions to rescue lipopolysaccharide-induced acute lung injury. Gene Ther. 23:489–499. 2016. View Article : Google Scholar : PubMed/NCBI

Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M and Tsui LC: Identification of the cystic fibrosis gene: Genetic analysis. Science. 245:1073–1080. 1989. View Article : Google Scholar : PubMed/NCBI

Riordan JR, Romments JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, et al: Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science. 245:1066–1073. 1989. View Article : Google Scholar : PubMed/NCBI

Rommens JM, Iannuzzi MC, Kerem B, Drumm ML, Melmer G, Dean M, Rozmahel R, Cole JL, Kennedy D, Hidaka N, et al: Identification of the cystic fibrosis gene: Chromosome walking and jumping. Science. 245:1059–1065. 1989. View Article : Google Scholar : PubMed/NCBI

Endres TM and Konstan MW: What is cystic fibrosis? JAMA. 327:1912022. View Article : Google Scholar : PubMed/NCBI

Rafeeq MM and Murad HAS: Cystic fibrosis: Current therapeutic targets and future approaches. J Transl Med. 15:842017. View Article : Google Scholar : PubMed/NCBI

Natarajan V: Is PI3K a villain in cystic fibrosis? Am J Respir Cell Mol Biol. 62:552–553. 2020. View Article : Google Scholar : PubMed/NCBI

Reilly R, Mroz MS, Dempsey E, Wynne K, Keely SJ, McKone EF, Hiebel C, Behl C and Coppinger JA: Targeting the PI3K/Akt/mTOR signalling pathway in cystic fibrosis. Sci Rep. 7:76422017. View Article : Google Scholar : PubMed/NCBI

Peckham D, Holland E, Range S and Knox AJ: Na+/K+ ATPase in lower airway epithelium from cystic fibrosis and non-cystic-fibrosis lung. Biochem Biophys Res Commun. 232:464–468. 1997. View Article : Google Scholar : PubMed/NCBI

Luczay A, Vásárhelyi B, Dobos M, Holics K, Ujhelyi R and Tulassay T: Altered erythrocyte sodium-lithium counter-transport and Na+/K(+)-ATPase activity in cystic fibrosis. Acta Paediatr. 86:245–247. 1997. View Article : Google Scholar : PubMed/NCBI

Miller TJ and Davis PB: FXYD5 modulates Na+ absorption and is increased in cystic fibrosis airway epithelia. Am J Physiol Lung Cell Mol Physiol. 294:L654–L664. 2008. View Article : Google Scholar : PubMed/NCBI

Raghavan D, Gao A, Ahn C, Kaza V, Finklea J, Torres F and Jain R: Lung transplantation and gender effects on survival of recipients with cystic fibrosis. J Heart Lung Transplant. 35:1487–1496. 2016. View Article : Google Scholar : PubMed/NCBI

Saint-Criq V, Kim SH, Katzenellenbogen JA and Harvey BJ: Non-genomic estrogen regulation of ion transport and airway surface liquid dynamics in cystic fibrosis bronchial epithelium. PLoS One. 8:e785932013. View Article : Google Scholar : PubMed/NCBI

Matalon S, Bartoszewski R and Collawn JF: Role of epithelial sodium channels in the regulation of lung fluid homeostasis. Am J Physiol Lung Cell Mol Physiol. 309:L1229–L1238. 2015. View Article : Google Scholar : PubMed/NCBI

Richeldi L, Collard HR and Jones MG: Idiopathic pulmonary fibrosis. Lancet. 389:1941–1952. 2017. View Article : Google Scholar : PubMed/NCBI

Cai M, Zhu M, Ban C, Su J, Ye Q, Liu Y, Zhao W, Wang C and Dai H: Clinical features and outcomes of 210 patients with idiopathic pulmonary fibrosis. Chin Med J (Engl). 127:1868–1873. 2014. View Article : Google Scholar : PubMed/NCBI

Li B, Huang X, Xu X, Ning W, Dai H and Wang C: The profibrotic effect of downregulated Na,K-ATPase β1 subunit in alveolar epithelial cells during lung fibrosis. Int J Mol Med. 44:273–280. 2019.PubMed/NCBI

Rodrigo R, Trujillo S, Bosco C, Orellana M, Thielemann L and Araya J: Changes in (Na + K)-adenosine triphosphatase activity and ultrastructure of lung and kidney associated with oxidative stress induced by acute ethanol intoxication. Chest. 121:589–596. 2002. View Article : Google Scholar : PubMed/NCBI

Nam LB and Keum YS: Regulation of NRF2 by Na⁺/K⁺-ATPase: Implication of tyrosine phosphorylation of Src. Free Radic Res. 54:883–893. 2020. View Article : Google Scholar : PubMed/NCBI

Wang J, Hu K, Cai X, Yang B, He Q, Wang J and Weng Q: Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis. Acta Pharm Sin B. 12:18–32. 2022. View Article : Google Scholar : PubMed/NCBI

Ludens JH, Clark MA, DuCharme DW, Harris DW, Lutzke BS, Mandel F, Mathews WR, Sutter DM and Hamlyn JM: Purification of an endogenous digitalislike factor from human plasma for structural analysis. Hypertension. 17:923–929. 1991. View Article : Google Scholar : PubMed/NCBI

Sophocleous A, Elmatzoglou I and Souvatzoglou A: Circulating endogenous digitalis-like factor(s) (EDLF) in man is derived from the adrenals and its secretion is ACTH-dependent. J Endocrinol Invest. 26:668–674. 2003. View Article : Google Scholar : PubMed/NCBI

Li B, Huang X, Liu Z, Xu X, Xiao H, Zhang X, Dai H and Wang C: Ouabain ameliorates bleomycin induced pulmonary fibrosis by inhibiting proliferation and promoting apoptosis of lung fibroblasts. Am J Transl Res. 10:2967–2974. 2018.PubMed/NCBI

La J, Reed EB, Koltsova S, Akimova O, Hamanaka RB, Mutlu GM, Orlov SN and Dulin NO: Regulation of myofibroblast differentiation by cardiac glycosides. Am J Physiol Lung Cell Mol Physiol. 310:L815–L823. 2016. View Article : Google Scholar : PubMed/NCBI

Orlov SN, La J, Smolyaninova LV and Dulin NO: Na+,K+-ATPase as a target for treatment of tissue fibrosis. Curr Med Chem. 26:564–575. 2019. View Article : Google Scholar : PubMed/NCBI

Johnson S, Sommer N, Cox-Flaherty K, Weissmann N, Ventetuolo CE and Maron BA: Pulmonary hypertension: A contemporary review. Am J Respir Crit Care Med. 208:528–548. 2023. View Article : Google Scholar : PubMed/NCBI

Mocumbi A, Humbert M, Saxena A, Jing ZC, Sliwa K, Thienemann F, Archer SL and Stewart S: Pulmonary hypertension. Nat Rev Dis Primers. 10:12024. View Article : Google Scholar : PubMed/NCBI

Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P, et al: 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 61:22008792023. View Article : Google Scholar : PubMed/NCBI

Kovacs G, Bartolome S, Denton CP, Gatzoulis MA, Gu S, Khanna D, Badesch D and Montani D: Definition, classification and diagnosis of pulmonary hypertension. Eur Respir J. 64:24013242024. View Article : Google Scholar : PubMed/NCBI

Poch D and Mandel J: Pulmonary hypertension. Ann Intern Med. 174:ITC49–ITC64. 2021. View Article : Google Scholar : PubMed/NCBI

Bubb KJ, Tang O, Gentile C, Moosavi SM, Hansen T, Liu CC, Di Bartolo BA and Figtree GA: FXYD1 is protective against vascular dysfunction. Hypertension. 77:2104–2116. 2021. View Article : Google Scholar : PubMed/NCBI

Pavlovic D, Hall AR, Kennington EJ, Aughton K, Boguslavskyi A, Fuller W, Despa S, Bers DM and Shattock MJ: Nitric oxide regulates cardiac intracellular Na⁺ and Ca²⁺by modulating Na/K ATPase via PKCε and phospholemman-dependent mechanism. J Mol Cell Cardiol. 61:164–171. 2013. View Article : Google Scholar : PubMed/NCBI

Hansen TS, Karimi Galougahi K, Tang O, Tsang M, Scherrer-Crosbie M, Arystarkhova E, Sweadner K, Bursill C, Bubb KJ and Figtree GA: The FXYD1 protein plays a protective role against pulmonary hypertension and arterial remodeling via redox and inflammatory mechanisms. Am J Physiol Heart Circ Physiol. 326:H623–H635. 2024. View Article : Google Scholar : PubMed/NCBI

Ghosh B, Kar P, Mandal A, Dey K, Chakraborti T and Chakraborti S: Ca2+ influx mechanisms in caveolae vesicles of pulmonary smooth muscle plasma membrane under inhibition of alpha2beta1 isozyme of Na+/K+-ATPase by ouabain. Life Sci. 84:139–148. 2009. View Article : Google Scholar : PubMed/NCBI

Fürstenwerth H: Ouabain-the insulin of the heart. Int J Clin Pract. 64:1591–1594. 2010. View Article : Google Scholar : PubMed/NCBI

Guerrero A, Herranz N, Sun B, Wagner V, Gallage S, Guiho R, Wolter K, Pombo J, Irvine EE, Innes AJ, et al: Cardiac glycosides are broad-spectrum senolytics. Nat Metab. 1:1074–1088. 2019. View Article : Google Scholar : PubMed/NCBI

Laredo J, Hamilton BP and Hamlyn JM: Secretion of endogenous ouabain from bovine adrenocortical cells: Role of the zona glomerulosa and zona fasciculata. Biochem Biophys Res Commun. 212:487–493. 1995. View Article : Google Scholar : PubMed/NCBI

De Angelis C and Haupert GT Jr: Hypoxia triggers release of an endogenous inhibitor of Na(+)-K(+)-ATPase from midbrain and adrenal. Am J Physiol. 274:F182–F188. 1998.PubMed/NCBI